Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery

Study led by Weill Cornell Medicine demonstrates identification of protein altering variants for population-scale protein quantitative trait loci studies Proteograph Product Suite enables scalable...

Related Keywords

Qatar ,Omid Farokhzad ,Patrick Schmidt ,Serafim Batzoglou ,Karsten Suhre ,Weill Cornell ,Carrie Mendivil ,Nasdaq ,Nature Communications ,Exchange Commission ,Seer Inc ,Weill Cornell Medicine ,Product Suite ,Virtual Metabolomics Core ,Weill Cornell Medicine Qatar ,Proteograph Assay ,Chief Executive Officer ,Proteograph Product Suite ,Chief Data Officer ,Private Securities Litigation Reform Act ,Markets ,